Ksiaa I, Abroug N, Kechida M, Zina S, Jelliti B, Khochtali S, Attia S, Khairallah M
Service d'ophtalmologie, hôpital universitaire Fattouma Bourguiba, faculté de médecine, université de Monastir, 5019 Monastir, Tunisie.
Service de médecine interne, hôpital universitaire Fattouma Bourguiba, faculté de médecine, université de Monastir, Monastir, Tunisie.
J Fr Ophtalmol. 2019 Apr;42(4):e133-e146. doi: 10.1016/j.jfo.2019.02.002. Epub 2019 Mar 5.
Behçet's disease is a chronic multisystem disorder characterized by relapsing inflammation for which the underlying histopathology is an occlusive vasculitis. The disease has a high prevalence in the Mediterranean region, Far and Middle Eastern countries. It is clinically characterized by oral and genital ulcerations, ocular inflammatory involvement, skin lesions, vascular involvement and numerous other systemic manifestations. Uveitis is by far the most common ocular manifestation of Behçet's disease. It typically presents in the form of relapsing-remitting panuveitis with retinal vasculitis that may result in severe visual loss. Management of Behçet's uveitis relies on corticosteroid therapy, conventional immunosuppressive drugs and biological agents and requires a close collaboration between ophthalmologist and internist. A better understanding of auto-inflammatory process and of the role of cytokines implicated in the pathogenesis of Behçet's disease will enable researchers to develop more specific and effective therapy.
白塞病是一种慢性多系统疾病,其特征为反复出现的炎症,潜在的组织病理学表现为闭塞性血管炎。该病在地中海地区、远东和中东国家具有较高的患病率。其临床特征为口腔和生殖器溃疡、眼部炎症、皮肤病变、血管受累以及许多其他全身表现。葡萄膜炎是白塞病迄今为止最常见的眼部表现。它通常表现为复发-缓解型全葡萄膜炎,并伴有视网膜血管炎,这可能导致严重的视力丧失。白塞病葡萄膜炎的治疗依赖于皮质类固醇疗法、传统免疫抑制药物和生物制剂,并且需要眼科医生和内科医生密切合作。更好地了解自身炎症过程以及细胞因子在白塞病发病机制中的作用,将使研究人员能够开发出更具特异性和有效性的治疗方法。